Yes.
And Race doesn't owe Amgen any favours.
e.g. Amgen made Race pay for the second preclinical.
Ann: Bisantrene Highly Active in a Multiple Myeloma Mouse Model, page-49
-
- There are more pages in this discussion • 34 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.68 |
Change
-0.020(1.18%) |
Mkt cap ! $282.9M | |||
| Open | High | Low | Value | Volume |
| $1.69 | $1.69 | $1.66 | $64.72K | 38.83K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 397 | $1.67 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.68 | 4541 | 1 |
View Market Depth
| Last trade - 12.30pm 18/09/2024 (20 minute delay) ? |
| RAC (ASX) Chart |